Hereditary Cancer Syndromes
Conditions
Interventions
Family-hereditary tumor syndrome:none
Non-hereditary tumor syndrome:none
Sponsors
Cancer Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Primary tumor of each organ, multiple malignant tumors of one single site are considered as a single primary tumor; 2. The tumor must have pathological slices or must be cytologically confirmed to be malignant and not metastasis of other organs; 3. Informed consent from the patient must be obtained prior to starting any study-related procedures and treatments, confirming that the patient is willing to participate in the study and to comply with the research-related requirements.
Exclusion criteria
Exclusion criteria: 1. Incomplete medical history or imaging data; 2. The patient withdraws from the study due to other physical or social reasons unrelated to the project; 3. Mental illness or other condition that affects patient compliance; Other serious diseases or medical conditions: 4. History of uncontrollable paroxysmal disease, including CNS diseases or mental disorders, and other situations in which investigator determines that the understanding and signing of informed consent might be affected; 5. Those who have undergone blood transfusion or stem cell therapy in the past one year; 6. Any other conditions that the investigator considers inappropriate for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| whole exome;cancer transcriptome;cancer proteome;DNA modifications; | — |
Countries
China
Contacts
Public ContactLiu Jiaqi
Cancer Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed